N-Fmoc-7-methyl-L-tryptophan CAS 1808268-53-2
video
N-Fmoc-7-methyl-L-tryptophan CAS 1808268-53-2

N-Fmoc-7-methyl-L-tryptophan CAS 1808268-53-2

Product Name:N-Fmoc-7-methyl-L-tryptophan
CAS NO.:1808268-53-2
Other Name:Fmoc-7-Me-Trp-OH

TNN specializes in food additives, pharmaceutical ingredients, Cosmetic Raw Materials, Fine Chemicals, etc. Please feel free to inquire if you have any needs.

Опис

 

 

20250820133551
 
 
N-Fmoc-7-methyl-L-tryptophan
CAS NO. 1808268-53-2
>98%
1kg/10kg/20kg/100kg
1.2kg/12kg/23kg/115kg
1kg/bag 10kg/bucket 20kg/bucket 100kg/bucket
ISO9001
24 month
100 g

 

 

 

N-Fmoc-7-methyl-L-Tryptophan CAS: 1808268-53-2 is a key advanced intermediate that empowers peptide drugs through site-specific methylation modification. The methyl group introduced at the seventh position of the tryptophan indole ring, through unique steric hindrance and hydrophobic effects, systematically optimizes the drug properties of therapeutic peptides, demonstrating great value in the development of a new generation of efficient, long-lasting, and safe peptide therapies.
The core mechanism of action of this molecule lies in the multiple positive effects brought about by its methyl modification. The introduction of 7-methyl first effectively shields the peptide chain through steric hindrance, making it difficult for proteases to recognize and degrade, thereby significantly enhancing the metabolic stability of peptide molecules and laying the structural foundation for prolonging the half-life of drugs in vivo. At the same time, this methylation modification moderately increases the hydrophobicity of the molecule, which helps improve its interaction with the cell membrane and is expected to enhance the peptide's ability to cross biological barriers such as the blood-brain barrier, creating conditions for the development of therapies for central nervous system diseases.
In drug development and application, the synergistic effect of these characteristics directly translates into significant clinical advantages. Peptide candidate drugs developed based on Fmoc-7-Me-Trp-OH may not only reduce the frequency of administration and improve patient compliance due to improved stability, but also reduce the required dose due to their enhanced delivery efficiency. More importantly, this precise local modification helps optimize the interaction conformation between peptides and targets, reducing off target effects while maintaining or even enhancing therapeutic efficacy, potentially reducing low toxicity and side effects, improving treatment window and overall safety.

 

 

 

product-800-800    product-2116-2116

pack in 1kg/bag 10kg/bucket 20kg/bucket

 

 

 

 
 

TNN MAKE YOUR LIFE BETTER.

6
10
2
product-1024-682

 

 

 

About Us

About Us 1

About Us 3

Популярні Мітки: n-fmoc-7-methyl-l-tryptophan cas 1808268-53-2, China, suppliers, manufacturers, factory, customized, wholesale, cheap, discount, low price, free sample

(0/10)

clearall